vs
PETMED EXPRESS INC（PETS）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
RE/MAX Holdings, Inc.的季度营收约是PETMED EXPRESS INC的1.7倍（$71.1M vs $40.7M），RE/MAX Holdings, Inc.净利率更高（2.0% vs -26.0%，领先28.0%），RE/MAX Holdings, Inc.同比增速更快（-1.8% vs -23.3%），RE/MAX Holdings, Inc.自由现金流更多（$33.5M vs $-9.2M），过去两年RE/MAX Holdings, Inc.的营收复合增速更高（-4.7% vs -20.9%）
PetMed Express，也叫PetMeds，是总部位于美国的线上宠物药房。该企业公开上市，主营宠物处方及非处方药物销售业务，是北美知名的宠物医药线上零售平台。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
PETS vs RMAX — 直观对比
营收规模更大
RMAX
是对方的1.7倍
$40.7M
营收增速更快
RMAX
高出21.4%
-23.3%
净利率更高
RMAX
高出28.0%
-26.0%
自由现金流更多
RMAX
多$42.7M
$-9.2M
两年增速更快
RMAX
近两年复合增速
-20.9%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.7M | $71.1M |
| 净利润 | $-10.6M | $1.4M |
| 毛利率 | 23.3% | — |
| 营业利润率 | -25.7% | 13.1% |
| 净利率 | -26.0% | 2.0% |
| 营收同比 | -23.3% | -1.8% |
| 净利润同比 | -1392.6% | -75.2% |
| 每股收益（稀释后） | $-0.50 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PETSRMAX
| Q4 25 | $40.7M | $71.1M | ||
| Q3 25 | $44.4M | $73.2M | ||
| Q2 25 | $51.2M | $72.8M | ||
| Q1 25 | $50.8M | $74.5M | ||
| Q4 24 | $52.0M | $72.5M | ||
| Q3 24 | $58.0M | $78.5M | ||
| Q2 24 | $66.2M | $78.5M | ||
| Q1 24 | $65.1M | $78.3M |
净利润PETSRMAX
| Q4 25 | $-10.6M | $1.4M | ||
| Q3 25 | $-8.5M | $4.0M | ||
| Q2 25 | $-34.2M | $4.7M | ||
| Q1 25 | $-11.6M | $-2.0M | ||
| Q4 24 | $-707.0K | $5.8M | ||
| Q3 24 | $2.3M | $966.0K | ||
| Q2 24 | $3.8M | $3.7M | ||
| Q1 24 | $-5.0M | $-3.4M |
毛利率PETSRMAX
| Q4 25 | 23.3% | — | ||
| Q3 25 | 28.0% | — | ||
| Q2 25 | 28.1% | — | ||
| Q1 25 | 29.9% | — | ||
| Q4 24 | 31.0% | — | ||
| Q3 24 | 32.3% | — | ||
| Q2 24 | 28.8% | — | ||
| Q1 24 | 29.3% | — |
营业利润率PETSRMAX
| Q4 25 | -25.7% | 13.1% | ||
| Q3 25 | -18.9% | 25.0% | ||
| Q2 25 | -66.7% | 19.3% | ||
| Q1 25 | -11.9% | 7.2% | ||
| Q4 24 | -0.9% | 5.9% | ||
| Q3 24 | 1.0% | 19.4% | ||
| Q2 24 | 6.6% | 20.6% | ||
| Q1 24 | -5.9% | 5.8% |
净利率PETSRMAX
| Q4 25 | -26.0% | 2.0% | ||
| Q3 25 | -19.2% | 5.4% | ||
| Q2 25 | -66.7% | 6.4% | ||
| Q1 25 | -22.9% | -2.6% | ||
| Q4 24 | -1.4% | 8.0% | ||
| Q3 24 | 4.0% | 1.2% | ||
| Q2 24 | 5.7% | 4.7% | ||
| Q1 24 | -7.7% | -4.3% |
每股收益（稀释后）PETSRMAX
| Q4 25 | $-0.50 | — | ||
| Q3 25 | $-0.41 | — | ||
| Q2 25 | $-1.65 | — | ||
| Q1 25 | $-0.56 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $0.11 | — | ||
| Q2 24 | $0.18 | — | ||
| Q1 24 | $-0.24 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.9M | $118.7M |
| 总债务越低越好 | — | $432.2M |
| 股东权益账面价值 | $32.8M | $452.4M |
| 总资产 | $88.0M | $582.5M |
| 负债/权益比越低杠杆越低 | — | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资PETSRMAX
| Q4 25 | $26.9M | $118.7M | ||
| Q3 25 | $36.1M | $107.5M | ||
| Q2 25 | $41.1M | $94.3M | ||
| Q1 25 | $54.7M | $89.1M | ||
| Q4 24 | $50.1M | $96.6M | ||
| Q3 24 | $52.0M | $83.8M | ||
| Q2 24 | $46.0M | $66.1M | ||
| Q1 24 | $55.3M | $82.1M |
总债务PETSRMAX
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | — | $435.3M | ||
| Q4 24 | — | $436.2M | ||
| Q3 24 | — | $437.2M | ||
| Q2 24 | — | $438.1M | ||
| Q1 24 | — | $439.0M |
股东权益PETSRMAX
| Q4 25 | $32.8M | $452.4M | ||
| Q3 25 | $43.1M | $448.1M | ||
| Q2 25 | $51.5M | $442.4M | ||
| Q1 25 | $85.1M | $433.5M | ||
| Q4 24 | $96.2M | $429.5M | ||
| Q3 24 | $96.4M | $423.1M | ||
| Q2 24 | $93.5M | $418.4M | ||
| Q1 24 | $96.7M | $412.0M |
总资产PETSRMAX
| Q4 25 | $88.0M | $582.5M | ||
| Q3 25 | $100.3M | $582.2M | ||
| Q2 25 | $109.8M | $574.8M | ||
| Q1 25 | $148.7M | $571.4M | ||
| Q4 24 | $144.8M | $581.6M | ||
| Q3 24 | $146.0M | $578.6M | ||
| Q2 24 | $152.7M | $571.4M | ||
| Q1 24 | $169.9M | $566.7M |
负债/权益比PETSRMAX
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.2M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | $-9.2M | $33.5M |
| 自由现金流率自由现金流/营收 | -22.7% | 47.1% |
| 资本支出强度资本支出/营收 | 0.1% | 10.4% |
| 现金转化率经营现金流/净利润 | — | 28.39× |
| 过去12个月自由现金流最近4个季度 | $-23.0M | $56.8M |
8季度趋势，按日历期对齐
经营现金流PETSRMAX
| Q4 25 | $-9.2M | $40.9M | ||
| Q3 25 | $-2.2M | $17.7M | ||
| Q2 25 | $-12.3M | $4.6M | ||
| Q1 25 | $7.0M | $5.7M | ||
| Q4 24 | $-1.2M | $59.7M | ||
| Q3 24 | $7.4M | $17.6M | ||
| Q2 24 | $-8.5M | $15.9M | ||
| Q1 24 | $7.1M | $9.4M |
自由现金流PETSRMAX
| Q4 25 | $-9.2M | $33.5M | ||
| Q3 25 | $-4.8M | $16.4M | ||
| Q2 25 | $-13.6M | $2.9M | ||
| Q1 25 | $4.6M | $4.0M | ||
| Q4 24 | $-1.9M | $53.0M | ||
| Q3 24 | $6.1M | $16.3M | ||
| Q2 24 | $-9.2M | $14.0M | ||
| Q1 24 | $5.9M | $6.8M |
自由现金流率PETSRMAX
| Q4 25 | -22.7% | 47.1% | ||
| Q3 25 | -10.8% | 22.4% | ||
| Q2 25 | -26.5% | 4.0% | ||
| Q1 25 | 9.1% | 5.3% | ||
| Q4 24 | -3.7% | 73.2% | ||
| Q3 24 | 10.6% | 20.8% | ||
| Q2 24 | -13.9% | 17.8% | ||
| Q1 24 | 9.0% | 8.6% |
资本支出强度PETSRMAX
| Q4 25 | 0.1% | 10.4% | ||
| Q3 25 | 5.9% | 1.8% | ||
| Q2 25 | 2.5% | 2.2% | ||
| Q1 25 | 4.7% | 2.3% | ||
| Q4 24 | 1.5% | 9.1% | ||
| Q3 24 | 2.2% | 1.7% | ||
| Q2 24 | 1.0% | 2.4% | ||
| Q1 24 | 1.9% | 3.3% |
现金转化率PETSRMAX
| Q4 25 | — | 28.39× | ||
| Q3 25 | — | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | 3.18× | 18.22× | ||
| Q2 24 | -2.27× | 4.29× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PETS
| Reorder | $34.0M | 84% |
| New Order | $5.0M | 12% |
| Membership Fees | $1.6M | 4% |
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
